Hassan Soleimanpour*, Samad Shams Vahdati, M.Bassir A.Fakhree
|
Original Research
COVID-19
Khalil Ansarin  , Ramin Tolouian, Mohammadreza Ardalan* , Ali Taghizadieh, Mojtaba Varshochi, Soheil Teimouri, Tahere Vaezi, Hamed Valizadeh, Parviz Saleh, Saeid Safiri , Kenneth R. Chapman
Based on a randomized clinical trial, bromhexine is proposed as a potential therapeutic option in COVID-19. A total of 78 patients with similar demographic and disease characteristics were treated with results showing a significant reduction in ICU admissions.
|
Aynur Karadağ Gürel* , Selçuk Gürel
As a result, it suggests that the enriched genes and new pathways emerging as a result of the analysis may help identify the group that responds poorly to treatment and the outcome of the treatment.
|
Gang He* , Mei Liu, Tang cong Chen, Li fen Huang, You qiang Ke
|
S Rehan Ahmad* , Md Zeyaullah* , Abdullah M. AlShahrani, Mohammad Suhail Khan, Adam Dawria, Ali Mohieldin, Haroon Ali, Abdelrhman AG Altijani, Mohammad Shane Alam, Munzila Mehdi, Sabika Akram, Ejaz Rizvi Hussain, Mohammad Amjad Kamal
|
Tejpal Yadav , Hemant Kumar Singh Yadav , Abhay Raizaday , Md Sabir Alam*
|
Mohsen Rashid , Mina Ramezani, Ommoleila Molavi, Zeinab Ghesmati, Behzad Baradaran, Mehdi Sabzichi, Fatemeh Ramezani*
|
Bahar Naseri , Amirhossein Mardi , Najibeh Shekari , Neda Shajari , Samin Abdolzadeh, Hossein Khorramdelazad, Amirhossein Hatami-Sadr, Milad Taghizadeh Anvar, Mohammad Reza Javan, Amirhossein Heibatollahi, Javad Masoumi , Farid Ghorbaninezhad* , Behzad Baradaran*
|
Nasim Vahidfar , Ayuob Aghanejad*
|
Sina Baharaghdam , Özkan Yildirim, Mohammadbagher Pirouzpanah, Danial Abbas kabiri, Shima Karimi, Mohammad Esfini Farahani, Amirhossein Aghapour, Ali Hassanzadeh, Amin Kamrani, Reza Mousavi Ardehaie, Amir Mehdizadeh, Parvin Hakimi, Javad Ahmadian Heris, Leili Aghebati-Maleki, Mehdi Yousefi
|